Home > Healthcare > Pharmaceuticals > Finished Drug Form > Oral Mucositis Treatment Market

Oral Mucositis Treatment Market Trends

  • Report ID: GMI9273
  • Published Date: Apr 2024
  • Report Format: PDF

Oral Mucositis Treatment Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as growing focus on preventive strategies, continuous innovation in targeted therapies, rise in personalized medicine approaches, and advancements in novel drug delivery systems, among other factors are propelling the industry growth.

  • Further, there is a growing focus on preventive strategies aimed at reducing the incidence and severity of oral mucositis. Healthcare providers are implementing proactive measures such as oral care protocols, cryotherapy, and the use of preventive medications to minimize the risk of mucositis in cancer patients undergoing treatment. These preventive strategies not only improve patient comfort but also help maintain treatment adherence and reduce healthcare costs associated with mucositis management.
  • Moreover, advances in molecular oncology have led to the development of targeted therapies for cancer treatment, some of which may have implications for oral mucositis management. Targeted therapies specifically designed to inhibit molecular pathways involved in mucositis pathogenesis are being explored as potential treatments. These therapies aim to mitigate mucositis-related inflammation and tissue damage while minimizing adverse effects on cancer treatment efficacy, thereby aforementioned factors are expected to drive the market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The oral mucositis treatment market was valued at USD 1.6 billion in 2023 and is expected to exhibit growth at 7.1% CAGR from 2024 – 2032, attributed to the ongoing advancements in cancer therapy, increasing prevalence of cancer, and rising geriatric population

The anti-inflammatory segment accounted for 30% of the market share in 2023, owing to the innovations in anti-inflammatory therapies.

North America oral mucositis treatment market size generated USD 586.9 million in 2023 and is anticipated to grow at 6.8% CAGR between 2024 – 2032, driven by prevalence of cancers, including head and neck cancers, leukemia, and lymphomas.

Amgen Inc., Basic Pharma Life Science Pvt Ltd., CANbridge Pharmaceuticals Inc., Enzychem Lifesciences Corporation, EpicentRx, Inc., Galera Therapeutics, Inc., Helsinn Healthcare SA., Innovation Pharmaceuticals Inc., Monopar Therapeutics, Inc., Pfizer Inc., Soleva Pharma, LLC. and Swedish Orphan Biovitrum AB

Oral Mucositis Treatment Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 150
  • Countries covered: 23
  • Pages: 110
 Download Free Sample